Does MIZORIBINE Cause Interstitial lung disease? 12 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Interstitial lung disease have been filed in association with MIZORIBINE. This represents 3.3% of all adverse event reports for MIZORIBINE.
12
Reports of Interstitial lung disease with MIZORIBINE
3.3%
of all MIZORIBINE reports
6
Deaths
5
Hospitalizations
How Dangerous Is Interstitial lung disease From MIZORIBINE?
Of the 12 reports, 6 (50.0%) resulted in death, 5 (41.7%) required hospitalization, and 3 (25.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIZORIBINE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does MIZORIBINE Cause?
Drug ineffective (36)
Off label use (29)
Cytomegalovirus infection (19)
Pneumonia (19)
Renal impairment (16)
Nephrotic syndrome (15)
Pyrexia (15)
Product use in unapproved indication (14)
Urinary tract infection (13)
Acute kidney injury (12)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which MIZORIBINE Alternatives Have Lower Interstitial lung disease Risk?
MIZORIBINE vs MOBOCERTINIB
MIZORIBINE vs MOCLOBEMIDE
MIZORIBINE vs MODAFINIL
MIZORIBINE vs MOGAMULIZUMAB
MIZORIBINE vs MOGAMULIZUMAB-KPKC